CureVac N.V.
CVAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $738,882 | $839,763 | $1,064,760 | $5,612,412 |
| - Cash | $481,748 | $402,452 | $495,797 | $811,464 |
| + Debt | $38,965 | $41,824 | $42,086 | $28,892 |
| Enterprise Value | $296,099 | $479,135 | $611,049 | $4,829,840 |
| Revenue | $535,180 | $53,758 | $67,420 | $102,990 |
| % Growth | 895.5% | -20.3% | -34.5% | – |
| Gross Profit | $429,351 | -$70,608 | -$116,573 | -$135,205 |
| % Margin | 80.2% | -131.3% | -172.9% | -131.3% |
| EBITDA | $209,690 | -$234,090 | -$209,386 | -$386,486 |
| % Margin | 39.2% | -435.5% | -310.6% | -375.3% |
| Net Income | $162,186 | -$260,167 | -$249,029 | -$411,716 |
| % Margin | 30.3% | -484% | -369.4% | -399.8% |
| EPS Diluted | 0.72 | -1.18 | -1.32 | -2.21 |
| % Growth | 161% | 10.6% | 40.3% | – |
| Operating Cash Flow | $101,851 | -$267,887 | -$286,177 | -$733,128 |
| Capital Expenditures | -$18,444 | -$55,200 | -$93,222 | -$127,901 |
| Free Cash Flow | $83,407 | -$323,087 | -$379,399 | -$861,029 |